Evaluating a new sizing algorithm for transcatheter aortic valve replacement in patients with bicuspid aortic stenosis
Official title: A Prospective Cohort Study of Bicuspid Case Selection and Valve Sizing Using the ABC Bicuspid Sizing Algorithm for Sapien 3 Balloon Expandable Valve
Run by World Health Research Inc. · NCT06991517 · Data updated 2026-11-12
This study is testing a new sizing method for heart valve replacement to see if it helps people with a specific heart condition feel better after their procedure.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 290 (estimated) |
| Sponsor | World Health Research Inc. Industry-sponsored |
| Locations | 20 sites (St Leonards, New South Wales and 19 other locations) |
| Status | Recruiting |
| Started | May 13, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2031 |
| Registry record updated | July 21, 2026 |
| Trial ID | NCT06991517 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with bicuspid aortic valve disease and severe aortic stenosis who are eligible for TAVR with a Sapien 3 valve.
✕Probably not a fit
Patients who are not suitable for TAVR or are treated with a valve other than the Sapien 3 will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the impact of the ABC Bicuspid Sizing Algorithm on clinical outcomes for patients with bicuspid aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) using the Sapien 3 valve. Approximately 290 patients will be enrolled, with their diagnostic images evaluated to determine the appropriate treatment and valve size. The study will track outcomes at baseline, procedure, hospital discharge, and follow-ups at 30 days and one year post-procedure. The study will also utilize advanced imaging techniques and artificial intelligence in select cases to enhance decision-making.
Why it matters
Potential benefit: If successful, this study could improve the technical and device success rates of TAVR procedures for patients with bicuspid aortic stenosis.
How similar studies have gone: While the use of sizing algorithms in TAVR is a growing area of interest, this specific approach using the ABC Bicuspid Sizing Algorithm is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have bicuspid aortic valve disease * Have severe aortic stenosis or mixed aortic stenosis and regurgitation requiring treatment * Have no other condition requiring surgical intervention * Have had a TAVR CT scan (retrospectively gated contrast enhanced acquisition) that is of diagnostic quality and includes multiphase reconstructions of the aortic root at the minimum available slice thickness (with at least three systolic and one diastolic phases) * Would be treated with a Sapien 3 valve if found to be anatomically suitable for TAVR * Have a suitable access route for TAVR with a Sapien 3 valve Exclusion Criteria: * Are treated with TAVR using a device other than a Sapien 3 valve * Are unable to be treated with TAVR due to intercurrent illness, clinical instability, or death on waitlist after being accepted for TAVR * TAVR considered high risk and not feasible due to risk of coronary occlusion, risk of sino tubular junction (STJ) injury and severe LVOT calcification * Annular area less than 275 mm² or more than 750 mm²
Where it's running
-
North Shore Private Hospital
St Leonards, New South Wales, Australia Recruiting -
Royal North Shore Hospital
St Leonards, New South Wales, Australia Recruiting -
The Prince Charles Hospital
Chermside, Queensland, Australia Recruiting -
St Andrew's War Memorial Hospital
Spring Hill, Queensland, Australia Recruiting -
The Alfred
Melbourne, Victoria, Australia Recruiting -
Fiona Stanley Hospital
Murdoch, Western Australia, Australia Recruiting
Show 14 more locations
-
Foothills Medical Centre
Calgary, Alberta, Canada Recruiting -
NovaScotia Health Authority- Halifax Infimary
Halifax, NovaScotia, Canada Recruiting -
Hamilton General Hospital
Hamilton, Ontario, Canada Recruiting -
University of Ottawa Heart Institute
Ottawa, Ontario, Canada Recruiting -
St. Michael's Hospital
Toronto, Ontario, Canada Recruiting -
Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval
Québec, Quebec, Canada Recruiting -
Fundación Cardioinfantil - LaCardio
Bogotá, Colombia Recruiting -
Centro Médico Nacional Siglo XXI
Mexico City, Mexico Recruiting -
Wellington Regional Hospital
Newtown, Wellington Region, New Zealand Recruiting -
Christchurch Hospital
Christchurch, New Zealand Recruiting -
National Heart Centre Singapore
Singapore, Singapore Recruiting -
Southlake Regional Health Centre
Newmarket, Ontario, Canada Not yet recruiting -
Hospital San Juan de Dios
San José, Provincia de San José, Costa Rica Not yet recruiting -
Ramathibodi Hospital
Bangkok, Thailand Not yet recruiting
Study contacts
- Principal investigator: Tej PM Sheth, MD, FRCPC — McMaster University, World Health Research Inc.
- Study coordinator: Sarah Tawadros, MD
- Email: sarah.tawadros@worldhealthresearch.ca
- Phone: 647-783-3521
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exercise and nutrition support before and after TAVI for older adults with aortic stenosis
This trial tests whether a personalized exercise program plus protein and iron supplements before and after a transcatheter valve replacement can help older adults with aortic stenosis recover better than standard care.
-
Association Between Aortic Valve Area Changes and Pulmonary Congestion After TAVI
This study tests whether improvements in aortic valve opening after TAVI relate to reductions in lung congestion measured by ultrasound in adults with severe aortic stenosis.
-
Systematic 14-day ambulatory heart monitoring after TAVI
After TAVI, patients with certain heart conduction abnormalities will try 14 days of wearable ECG monitoring to see if it lowers the chances of sudden death, symptomatic heart rhythm problems, or stroke within a year compared to standard follow-up.
-
Echo-AVCS: Drawing AI-powered clues from heart scans to confirm severe aortic stenosis
This study tests an AI-based echocardiography score to help confirm severe aortic stenosis in adults who are also getting CT calcium scoring.
-
TAVI without on-site heart surgery: can selected centers do it safely?
This trial tests whether transcatheter aortic valve implantation can be done safely in certain hospitals that don’t have on-site cardiac surgery, for patients with severe aortic stenosis who are appropriately selected.
-
Willem AI for early detection of aortic stenosis from a 12‑lead ECG
This project will test whether the Willem AI can detect aortic stenosis from routine 12‑lead ECGs in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.